Induction chemotherapy followed by response evaluation and esophagectomy for advanced esophageal cancer
European Journal of Surgical Oncology · 2024
DOI: 10.1016/j.ejso.2024.107968 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Surgical Oncology, 2024. Verfasst von Charlène J van der Zijden und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: c.vanderzijden@erasmusmc.nl. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Adenocarcinoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
INTRODUCTION: Patients with limited metastatic/advanced esophageal cancer not amenable for neoadjuvant therapy plus surgery have a poor prognosis and often receive palliative care. Alternatively, induction chemotherapy with response evaluation can be considered and in some patients surgery with curative intent may become feasible. The aim of this study was to evaluate the outcomes of patients treated with induction chemotherapy and to identify patient and/or tumor characteristics associated with survival. MATERIAL AND METHODS: Patients with esophageal or junctional cancer who underwent induction chemotherapy between 2005 and 2021 were identified from an institutional database of a tertiary referral center. Response to therapy was assessed by (18F-FDG PET)/CT. Response to therapy and treatment options, including surgery or palliation, were discussed in the multidisciplinary tumor board. Overall survival (OS) was calculated using the Kaplan Meier method. Uni- and multivariable analyses were performed to identify prognostic factors for survival. RESULTS: 238 patients were identified. The majority had esophageal adenocarcinoma (68.9 %) and were treated with a taxane/platinum-based chemotherapy (79.4 %). Response evaluation was performed in 233 patients and 154 of 238 patients (64.7 %) underwent surgical exploration. Resection was performed in 127 patients (53.4 %) resulting in a median and 5-year OS of 26.3 months (95 % CI 18.8-33.8) and 29.6 %, respectively. Presence of T4b (HR = 2.01, 95 % CI 1.02-3.92) and poorly differentiated tumor (HR = 1.45, 95 % CI 1.02-2.10) was associated with worse survival (p = 0.04). CONCLUSION: In carefully selected patients with advanced disease not amenable for standard curative treatment, induction chemotherapy followed by esophagectomy may result in a 5-year overall survival of approximately 30 %.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: c.vanderzijden@erasmusmc.nl.
- Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
- Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
- Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
- Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
- Department of Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Zitieren
APA
van der Zijden, C. J., van der Sluis, P. C., Mostert, B., Nuyttens, J. J. M. E., Spaander, M. C. W., Toxopeus, E. L. A., Valkema, R., Beerepoot, L. V., van Halteren, H. K., Lagarde, S. M., & Wijnhoven, B. P. L. (2024). Induction chemotherapy followed by response evaluation and esophagectomy for advanced esophageal cancer. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2024.107968
Vancouver
van der Zijden CJ, van der Sluis PC, Mostert B, Nuyttens JJME, Spaander MCW, Toxopeus ELA, et al. Induction chemotherapy followed by response evaluation and esophagectomy for advanced esophageal cancer. European Journal of Surgical Oncology. 2024. doi:10.1016/j.ejso.2024.107968
BibTeX
@article{vanderZijden2024,
author = {van der Zijden, Charlène J and van der Sluis, Pieter C and Mostert, Bianca and Nuyttens, Joost J M E and Spaander, Manon C W and Toxopeus, Eelke L A and Valkema, Roelf and Beerepoot, Laurens V and van Halteren, Henk K and Lagarde, Sjoerd M and Wijnhoven, Bas P L},
title = {Induction chemotherapy followed by response evaluation and esophagectomy for advanced esophageal cancer},
journal = {European Journal of Surgical Oncology},
year = {2024},
doi = {10.1016/j.ejso.2024.107968}
}
EUVIMED